feed,title,long_url,short_url
Benzinga,AYRO Clocks 83% Revenue Growth In Q2,https://benzinga.com/news/earnings/21/08/22450834/ayro-clocks-83-revenue-growth-in-q2,https://j.mp/3fULNCk
Benzinga,I-Mab Stock Is Trading Lower After Unveiling Mid-Stage Trial Data Of Plonmarlimab In Hospitalized COVID-19 Patients,https://benzinga.com/general/biotech/21/08/22442425/i-mab-stock-is-trading-lower-after-unveiling-mid-stage-trial-data-of-plonmarlimab-in-hospitalized,https://j.mp/3Azq2zY
